119 related articles for article (PubMed ID: 3404)
1. Physiological disposition and metabolism of (3H)bitolterol in man and dog.
Shargel L; Dorrbecker SA
Drug Metab Dispos; 1976; 4(1):72-8. PubMed ID: 3404
[TBL] [Abstract][Full Text] [Related]
2. Physiological disposition and metabolism of N-t-butylarterenol and its di-p-toluate ester (bitolterol) in the rat.
Shargel L; Dorrbecker SA; Levitt M
Drug Metab Dispos; 1976; 4(1):65-71. PubMed ID: 3403
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of labetalol by animals and man.
Martin LE; Hopkins R; Bland R
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
[TBL] [Abstract][Full Text] [Related]
4. Physiological disposition and metabolism of 2-aminomethyl-4-(1,1-dimethylethyl)-6-iodophenol hydrochloride.
Tocco DJ; deLuna FA; Duncan AE; Walker RW; Arison BH; Vandenheuvel WJ
Drug Metab Dispos; 1979; 7(5):330-4. PubMed ID: 40776
[TBL] [Abstract][Full Text] [Related]
5. Studies on bitolterol, di-p-toluate ester of N-tert.-butylarterenol: a new long-acting bronchodilator with reduced cardiovascular effects.
Minatoya H
J Pharmacol Exp Ther; 1978 Sep; 206(3):515-27. PubMed ID: 702319
[TBL] [Abstract][Full Text] [Related]
6. Physiological disposition and metabolism of timolol in man and laboratory animals.
Tocco DJ; Duncan AE; Delauna FA; Hucker HB; Gruber VF; Vandenheuvel WJ
Drug Metab Dispos; 1975; 3(5):361-70. PubMed ID: 241617
[TBL] [Abstract][Full Text] [Related]
7. Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicyclic acid, a new salicylate.
Tocco DJ; Breault GO; Zacchei AG; Steelman SL; Perrier CV
Drug Metab Dispos; 1975; 3(6):453-66. PubMed ID: 1220
[TBL] [Abstract][Full Text] [Related]
8. Disposition and metabolism of finasteride in dogs.
Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
[TBL] [Abstract][Full Text] [Related]
9. Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man.
Zacchei AG; Weidner LL; Besselaar GH; Raftery EB
Drug Metab Dispos; 1976; 4(4):387-401. PubMed ID: 8295
[TBL] [Abstract][Full Text] [Related]
10. The comparative metabolism and disposition of penfluridol-3H in the rat, rabbit, dog, and man.
Grindel JM; Migdalof BH; Cressman WA
Drug Metab Dispos; 1979; 7(5):325-9. PubMed ID: 40775
[TBL] [Abstract][Full Text] [Related]
11. The influences of the route of administration on the metabolism and excretion of bitolterol, a new bronchodilator, in the rat.
Aimoto T; Ito O; Kimura R; Murata T; Ito K
Xenobiotica; 1979 Mar; 9(3):173-80. PubMed ID: 473792
[TBL] [Abstract][Full Text] [Related]
12. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of 14C-estazolam in dogs and humans.
Machinist JM; Bopp BA; Anderson DJ; Granneman GR; Sonders RC; Tolman K; Buchi K; Rollins D
Xenobiotica; 1986 Jan; 16(1):11-20. PubMed ID: 2868576
[TBL] [Abstract][Full Text] [Related]
14. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog.
Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH
Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.
Vickers S; Duncan CA; Slaughter DE; Arison BH; Greber T; Olah TV; Vyas KP
Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219
[TBL] [Abstract][Full Text] [Related]
16. Comparative study on the disposition of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and dopamine hydrochloride in rats and dogs.
Yoshikawa M; Endo H; Otsuka M; Yamaguchi I; Harigaya S
Drug Metab Dispos; 1988; 16(5):754-8. PubMed ID: 2906602
[TBL] [Abstract][Full Text] [Related]
17. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
18. Metabolism and disposition of sulfinalol in laboratory animals.
Benziger DP; Fritz A; Edelson J
Drug Metab Dispos; 1981; 9(6):493-8. PubMed ID: 6120804
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
Prakash C; Cui D
Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
[TBL] [Abstract][Full Text] [Related]
20. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
